Text size
Menu
Home / Education & Practice Supports/ Clinical Tools & Resources

Filter

Filters
Publication date
Last Updated
Showing 1 - 7 of 7
SORT:

DI Referral Guidelines - Urology, adrenal and genitourinary systems

Type:

Guideline

Source:

Canadian Association of Radiologists

Looking for information about clinical and diagnostic investigations appropriate for patients with urological, adrenal, or genitourinary related concerns?

 

The Canadian Association of Radiologists supports your decision making by providing a succinct listing of investigations indicated for these conditions.

Tags: Diagnostic Imaging, Urology

Prostate Cancer Screening (2014)

Type:

Clinical Tool

Source:

Canadian Task Force on Preventive Health Care

Are you looking for a summary around the benefits and harms of PSA screening for prostate cancer?

 

The Canadian Task Force visually summarizes the benefits and risks, helping you to discuss with your patients and decide on the best option.

Tags: Cancer Screening, Urology

Managing Urinary Incontinence in Women Tool

Type:

Clinical Tool

Source:

Centre for Effective Practice

Did you know that urinary incontinence is the most common cause of long-term care centre admission in Canada?

 

The Centre for Effective Practice (CEP) created this reference document with topics including screening, diagnosis, and pharmacological management. Refer to the Managing Urinary Incontinence in Women Tool when seeing female patients with new onset or ongoing urinary incontinence symptoms.

Tags: Care of the Elderly, Urology

#270 Burning Evidence for Fosfomycin in Cystitis

Type:

PEER Tools for Practice

Source:

PEER Tools for Practice

Is fosfomycin (Monurol®) effective for urinary tract infections (UTIs)?

 

This PEER Tool for Practice summarizes the evidence on fosfomycin (Monurol®) effectiveness for treatment of uncomplicated UTIs. Consider this resource when making treatment decisions for a UTI.

Tags: Urology

#316 To Pee or Not to Pee: Combination agents for benign prostatic hypertrophy

Type:

PEER Tools for Practice

Source:

PEER Tools for Practice

Is combination therapy with alpha-blockers and 5-alpha reductase inhibitors (5ARI) more efficacious than alpha-blockers alone for patients with benign prostatic hypertrophy?

 

This PEER Tool for Practice provides the latest evidence that adding 5ARIs to alpha-blockers reduces the number of men with clinical progression, and the number needing BPH surgery. However, drug-related adverse effects are increased with combination therapy.

Tags: Urology

#319 Should a ‘flozin’ be chosen? Part 2: SGLT2 inhibitors in patients with chronic kidney disease

Type:

PEER Tools for Practice

Source:

PEER Tools for Practice

Wondering if sodium-glucose cotransporter 2 inhibitors (SGLT2i) have any effect on patient-relevant outcomes in chronic kidney disease (CKD)?

 

This PEER Tool for Practice examines the evidence for SGLT2i treatment in patients with CKD. Read this article to see the impact of SGLT2 inhibitors in CKD.

Tags: Endocrinology and Metabolism, Nephrology, Urology

#322 A dose a day keeps the UTI away?

Type:

PEER Tools for Practice

Source:

PEER Tools for Practice

What is the efficacy of antibiotic prophylaxis for recurrent urinary tract infections (UTI) in non-pregnant women?

 

This PEER Tool for Practice provides the latest evidence on whether antibiotic treatment decreases the risk of recurrent UTIs in non-pregnant women. Refer to this article when considering how to treat recurrent UTIs in your female patients.

Tags: Urology